Do Benzodiazepines Impair Motor and Nonmotor Symptoms in a Sample of Parkinson’s Disease Patients?

Wendy Gaztanaga(University of Miami), Bonnie Levin(University of Miami), Marina Sarno(University of Miami), Jason Margolesky(University of Miami), Jonathan Jagid(University of Miami), Henry Moore(University of Miami), Carlos Singer(University of Miami Health System), Corneliu Luca(University of Miami Health System)

Cureus

February 8, 2021

10.7759/cureus.13220

Cited by 4

Related Papers

Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease

|JAMA|2016|397

Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder

|Sleep Medicine|2013|391

Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy—a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group

|Sleep Medicine|2013|238

Subthalamic nucleus deep brain stimulation with a multiple independent constant current-controlled device in Parkinson's disease (INTREPID): a multicentre, double-blind, randomised, sham-controlled study

|The Lancet Neurology|2020|155

A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease

|Neurology|2016|137